FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4360616054> ?p ?o ?g. }

• W4360616054 endingPage "857" @default.
• W4360616054 startingPage "845" @default.
• W4360616054 abstract "Background Therapeutic drug monitoring and Model-informed precision dosing allow dose individualization to increase drug effectivity and reduce toxicity. Objectives To evaluate the available evidence on the clinical efficacy of individualized antimicrobial dosing optimization. Methods Data sources: PubMed, Embase, Web of Science, and Cochrane Library databases from database inception to 11 November 2022. Study eligibility criteria Published peer-reviewed randomized controlled trials. Participants Human subjects aged ≥18 years receiving an antibiotic or antifungal drug. Interventions Patients receiving individualized antimicrobial dose adjustment. Assessment of risk of bias Cochrane risk-of-bias tool for randomized trials. Methods of data synthesis The primary outcome was the risk of mortality. Secondary outcomes included target attainment, treatment failure, clinical and microbiological cure, length of stay, treatment duration, and adverse events. Effect sizes were pooled using a random-effects model. Statistical heterogeneity was assessed by inconsistency testing (I2). Results Ten randomized controlled trials were included in the meta-analysis (1241 participants; n = 624 in the individualized antimicrobial dosing group and n = 617 in the control group). Individualized antimicrobial dose optimization was associated with a numerical decrease in mortality (risk ratio [RR] = 0.86; 95% CI, 0.71–1.05), without reaching statistical significance. Moreover, it was associated with significantly higher target attainment rates (RR = 1.41; 95% CI, 1.13–1.76) and a significant decrease in treatment failure (RR = 0.70; 95% CI, 0.54–0.92). Individualized antimicrobial dose optimization was associated with improvement, but not significant in clinical cure (RR = 1.33; 95% CI, 0.94–1.33) and microbiological outcome (RR = 1.25; CI, 1.00–1.57), as well as with a significant decrease in the risk of nephrotoxicity (RR = 0.55; 95% CI, 0.31–0.97). Conclusions This meta-analysis demonstrated that target attainment, treatment failure, and nephrotoxicity were significantly improved in patients who underwent individualized antimicrobial dose optimization. It showed an improvement in mortality, clinical cure or microbiological outcome, although not significant." @default.
• W4360616054 created "2023-03-24" @default.
• W4360616054 creator A5005906492 @default.
• W4360616054 creator A5007882108 @default.
• W4360616054 creator A5013617676 @default.
• W4360616054 creator A5087790746 @default.
• W4360616054 date "2023-07-01" @default.
• W4360616054 modified "2023-10-02" @default.
• W4360616054 title "Individualized antimicrobial dose optimization: a systematic review and meta-analysis of randomized controlled trials" @default.
• W4360616054 cites W1487933470 @default.
• W4360616054 cites W1971624521 @default.
• W4360616054 cites W1997152162 @default.
• W4360616054 cites W1998611869 @default.
• W4360616054 cites W2035387023 @default.
• W4360616054 cites W2059267457 @default.
• W4360616054 cites W2099570512 @default.
• W4360616054 cites W2101416655 @default.
• W4360616054 cites W2105064679 @default.
• W4360616054 cites W2113717321 @default.
• W4360616054 cites W2119605658 @default.
• W4360616054 cites W2121189212 @default.
• W4360616054 cites W2126930838 @default.
• W4360616054 cites W2128912763 @default.
• W4360616054 cites W2149613723 @default.
• W4360616054 cites W2167943565 @default.
• W4360616054 cites W2170892587 @default.
• W4360616054 cites W2473016454 @default.
• W4360616054 cites W2614741637 @default.
• W4360616054 cites W2777633015 @default.
• W4360616054 cites W2791781902 @default.
• W4360616054 cites W2894527590 @default.
• W4360616054 cites W2929478224 @default.
• W4360616054 cites W2963222371 @default.
• W4360616054 cites W2972401648 @default.
• W4360616054 cites W2983542967 @default.
• W4360616054 cites W3022327571 @default.
• W4360616054 cites W3030013219 @default.
• W4360616054 cites W3092871709 @default.
• W4360616054 cites W3095869439 @default.
• W4360616054 cites W3106136066 @default.
• W4360616054 cites W3126910175 @default.
• W4360616054 cites W3129128302 @default.
• W4360616054 cites W3144543375 @default.
• W4360616054 cites W3217395775 @default.
• W4360616054 cites W4200198495 @default.
• W4360616054 cites W4210402439 @default.
• W4360616054 cites W4214735255 @default.
• W4360616054 cites W4226282851 @default.
• W4360616054 cites W4283262644 @default.
• W4360616054 cites W4289205101 @default.
• W4360616054 cites W4294683684 @default.
• W4360616054 cites W4308766976 @default.
• W4360616054 cites W4309977676 @default.
• W4360616054 doi "https://doi.org/10.1016/j.cmi.2023.03.018" @default.
• W4360616054 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36965694" @default.
• W4360616054 hasPublicationYear "2023" @default.
• W4360616054 type Work @default.
• W4360616054 citedByCount "4" @default.
• W4360616054 countsByYear W43606160542023 @default.
• W4360616054 crossrefType "journal-article" @default.
• W4360616054 hasAuthorship W4360616054A5005906492 @default.
• W4360616054 hasAuthorship W4360616054A5007882108 @default.
• W4360616054 hasAuthorship W4360616054A5013617676 @default.
• W4360616054 hasAuthorship W4360616054A5087790746 @default.
• W4360616054 hasConcept C126322002 @default.
• W4360616054 hasConcept C168563851 @default.
• W4360616054 hasConcept C177713679 @default.
• W4360616054 hasConcept C178790620 @default.
• W4360616054 hasConcept C185592680 @default.
• W4360616054 hasConcept C197934379 @default.
• W4360616054 hasConcept C2776478404 @default.
• W4360616054 hasConcept C2777288759 @default.
• W4360616054 hasConcept C44249647 @default.
• W4360616054 hasConcept C4937899 @default.
• W4360616054 hasConcept C535046627 @default.
• W4360616054 hasConcept C71924100 @default.
• W4360616054 hasConcept C82789193 @default.
• W4360616054 hasConcept C95190672 @default.
• W4360616054 hasConceptScore W4360616054C126322002 @default.
• W4360616054 hasConceptScore W4360616054C168563851 @default.
• W4360616054 hasConceptScore W4360616054C177713679 @default.
• W4360616054 hasConceptScore W4360616054C178790620 @default.
• W4360616054 hasConceptScore W4360616054C185592680 @default.
• W4360616054 hasConceptScore W4360616054C197934379 @default.
• W4360616054 hasConceptScore W4360616054C2776478404 @default.
• W4360616054 hasConceptScore W4360616054C2777288759 @default.
• W4360616054 hasConceptScore W4360616054C44249647 @default.
• W4360616054 hasConceptScore W4360616054C4937899 @default.
• W4360616054 hasConceptScore W4360616054C535046627 @default.
• W4360616054 hasConceptScore W4360616054C71924100 @default.
• W4360616054 hasConceptScore W4360616054C82789193 @default.
• W4360616054 hasConceptScore W4360616054C95190672 @default.
• W4360616054 hasFunder F4320335254 @default.
• W4360616054 hasFunder F4320338337 @default.
• W4360616054 hasIssue "7" @default.
• W4360616054 hasLocation W43606160541 @default.
• W4360616054 hasLocation W43606160542 @default.
• W4360616054 hasOpenAccess W4360616054 @default.

• next